News

2025 Financial Calendar for Reitir Fastar eignafélag hf.

2025 Financial Calendar for Reitir Fastar eignafélag hf.

Financial Reporting Schedule for Reitir Fastar eignafélag hf.

Reitir Fastar eignafélag hf. has outlined a comprehensive schedule for its financial reports and key meetings throughout 2025. The company aims to maintain transparency and keep investors informed with timely updates on its financial performance.

Key Dates in the Financial Calendar

The following key dates have been announced for Reitir's financial reporting and annual events:

Release of Management Report for 2024

Scheduled for release on January 27, 2025, this report will provide insights into the financial outcomes and strategic direction of the company for the previous year.

Annual Financial Report and Sustainability Information for 2024

On March 3, 2025, Reitir will publish its annual financial report alongside its annual report and sustainability disclosures, demonstrating its commitment to responsible governance and environmental stewardship.

Annual General Meeting for 2025

The Annual General Meeting (AGM) will take place on April 2, 2025, where shareholders can discuss the company's performance and future prospects directly with the board of directors.

Quarterly Performance Reports

Reitir will also share its quarterly financial results, with the first quarter’s performance being announced on May 12, 2025. The company will follow this with reports for the second quarter on August 21, 2025, and the third quarter on November 10, 2025, providing regular updates and insights into its operational effectiveness.

Future Financial Announcements

Looking ahead, several significant disclosures will follow in 2026. The management report for 2025 is expected on January 26, 2026, with the annual report and sustainability information for 2025 releasing on March 2, 2026. The subsequent annual general meeting is set for March 25, 2026.

Important Considerations

All financial disclosures will occur after the market close, ensuring that stakeholders have adequate time to process the information presented. The aforementioned dates are subject to changes, and stakeholders are encouraged to remain updated on any announcements from Reitir.

Contact Information

For further inquiries, Einar Þorsteinsson, the Chief Financial Officer, is available for contact at 669 4416 or via email at einar@reitir.is.

Frequently Asked Questions

What is the significance of the annual general meeting?

The annual general meeting is crucial for shareholders to voice their opinions, vote on key company matters, and interact with the board of directors.

Will these financial reports be available publicly?

Yes, Reitir will publish these reports publicly to ensure transparency and informed decision-making by investors.

How often does Reitir provide financial updates?

Reitir provides updates quarterly, alongside an annual report and management discussions to keep stakeholders informed regularly.

Can I ask questions during the annual general meeting?

Yes, shareholders are encouraged to participate actively and ask questions during the AGM.

Where can I find more information about Reitir’s financial health?

Investors can find detailed financial information in the company’s annual reports, quarterly updates, and other public disclosures available on its official site.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 6

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 3

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 12

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
More News Articles